Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas - A possibility for organ preservation

Radiotherapy and Oncology

Volumn 68, Issue 2, 2003, Pages 163-170

  Pfreundner, Leo ^a   Hoppe, Florian ^a   Willner, Jochen ^a   Preisler, Verena ^a   Bratengeier, Klaus ^a   Hagen, Rudolf ^a   Helms, Jan ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CT based radiotherapy; Hypopharyngeal carcinoma; Induction chemotherapy; Laryngeal carcinoma; Larynx preservation

Indexed keywords

CISPLATIN; CLEMASTINE; DEXAMETHASONE; GRANISETRON; PACLITAXEL; RANITIDINE; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONSTIPATION; DIARRHEA; DRUG FEVER; DYSPHAGIA; EAR NOSE THROAT SURGERY; EDEMA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HOARSENESS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOPHARYNX CARCINOMA; HYPOTENSION; LARYNGECTOMY; LARYNX CARCINOMA; LEUKOPENIA; LIVER TOXICITY; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PARESTHESIA; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; SENSORY DYSFUNCTION; SIDE EFFECT; THROMBOCYTOPENIA; VERTIGO; XEROSTOMIA; ADJUVANT THERAPY; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; HYPOPHARYNX TUMOR; LARYNX TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMAGING, THREE-DIMENSIONAL; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PROSPECTIVE STUDIES; RADIATION INJURIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542604555     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00076-8     Document Type: Article

References (39)

1. Adelstein D.J. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol. 10:1998;213-218.
2. Bratengeier K., Pfreundner L., Flentje M. Radiation techniques for head and neck cancer. Radiother Oncol. 56:2000;209-220.
3. Choy H., Rodriguez F.F., Koester S., et al. Investigation of taxol as potential radiation sensitizer. Cancer. 71:1993;3774-3778.
4. De Andrés L., Brunet J., Lopez-Pousa A., et al. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope. 105:1995;822-826.
5. Dimery I.X., Hong W.K. Overview of combined modality treatment for head and neck cancer. J. Natl Cancer Inst. 85:1993;95-111.
6. Dunphy F.R., Dunleavy T.L., Harrison B.R., et al. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 and 1999. Cancer. 91:2001;940-948.
7. Eisbruch A., Thornton A.F., Urba S., et al. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. J Clin Oncol. 14:1996;2322-2330.
8. E.O.R.T.C.: Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemo-radiotherapy in resectable hypopharynx and larynx cancers. E.O.R.T.C. Trial 24 954, Final version, June 1996:6.
9. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Bol Phys. 48:2000;7-16.
10. Goepfert H., Jesse R.H., Fletcher G.H., et al. Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx. Laryngoscope. 85:1975;14-32.
11. Harwood A.R., Hawkins N.V., Beale F.A., et al. Management of advanced glottic cancer: a 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys. 5:1979;899-904.
12. Harwood A.R., Beale F.A., Cummings B.J., et al. Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys. 9:1983;311-319.
13. Hermans R., Van den Bogaert W., Rijnders A., et al. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys. 44:1999;755-765.
14. Jacobs C. Adjuvant and neoadjuvant treatment of head and neck cancers. Semin Oncol. 18:1991;504-514.
15. Jaulerry C., Rodriguez J., Brunin F., et al. Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys. 23:1992;483-489.
16. Karim B.M.F., Kralendonk J.H., Njo K.H., et al. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic view point. Int J Radiat Oncol Biol Phys. 13:1987;1625-1633.
17. Kirchner J.A., Owen J.R. Five hundred cancers of the larynx and the pyriform sinus. Results of treatment by radiation and surgery. Laryngoscope. 87:1977;1288-1303.
18. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 88:1996;890-899.
19. Machtay M., Aviles V., Kigerman M.M., et al. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy for unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 44:1999;311-315.
20. MacKenzie R.G., Franssen E., Bologh J.M., et al. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys. 147:2000;65-71.
21. Maor M.H., Berkey B., Forastiere A., et al. Larynx preservation and tumor control in stage II and IV laryngeal cancer: a three-arm randomized Intergroup Trial: RTOG 91-11. Int J Radiat Oncol Biol Phys. 54:2002;2.
22. Mendenhall W.M., Million R.R., Sharkey D.E., et al. Stage T3 squamous cell carcinoma of the glottic larynx treated with surgery and/or radiation therapy. Int J Radiat Oncol Biol Phys. 10:1984;357-363.
23. Mendenhall W.M., Parsons J.T., Mancuso A.A., et al. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck. 18:1996;24-35.
24. National Cancer Institute NCI. Common toxicity criteria. Division of cancer treatment, National Cancer Institute, Bethesda, Maryland (USA) 1988.
25. Newkirk K.A., Cullen K.J., Harter K.W., et al. Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck. 23:2001;73-79.
26. Parsons J.T., Mendenhall W.M., Mancuso A.A., et al. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck. 11:1989;123-128.
27. Pfreundner L., Pahnke J., Desing A., et al. Systematik der zervikalen Lymphknotenmetastasierung von Larynx- und Hypopharynxkarzinomen - eine klinisch-computertomographische Studie unter besonderer Berücksichtigung der Ausdehnung des Primärtumors. Laryngo-Rhino-Otol. 75:1996;602-610.
28. Pfreundner L., Pahnke J., Willner J. Systematics in lymphatic tumor spread of carcinomas of the upper aerodigestive tract- a clinical study based on embryologic data. Eur Arch Otorhinolarygol. 257:2000;561-569.
29. Pfreundner L., Willner J., Marx A., et al. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys. 47:2000;1287-1297.
30. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analysis of updated individual data. Lancet. 355:2000;949-955.
31. Radiation Therapy Oncology Group. Acute and late radiation morbidity scoring. (2 tables written communication) 1984.
32. Richard J.M., Sancho-Garnier H., Pessey J.J., et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 34:1998;224-228.
33. Steiner W., Ambrosch P., Hess C.F., et al. Organ preservation by transoral laser microsurgery of piriform sinus carcinoma. Otolaryngol Head Neck Surg. 124:2001;58-67.
34. Strong M.S., Jako G.J. Laser surgery in the larynx. Early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol. 81:1972;791-798.
35. Terrell J.E., Fisher S.C., Wolf G.T. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 124:1998;964-971.
36. Tishler R.B., Busse P.M., Norris C.M., et al. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys. 43:1999;1001-1008.
37. Willner J., Hädinger U., Neumann M., et al. Three dimensional variability in patient positioning using bite block immobilization in 3D-conformal radiation treatment for ENT-tumors. Radiother Oncol. 43:1997;315-321.
38. Willner J., Baier K., Pfreundner L., et al. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol. 38:1999;1025-1030.
39. Wolf G.T., Hong W.K., Fisher S., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 324:1991;1685-1690.